Microalbuminuria in Type 2 diabetes: An independent predictor of cardiovascular mortality

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 4, 1996, Pages 519-525

  Beilin, J ^a   Stanton, K G ^a   McCann, V J ^b   Knuiman, M W ^b   Divitini, M L ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Albuminuria; Cardiovascular mortality; Diabetes; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK FACTOR;

EID: 0029764380     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00598.x     Document Type: Article

References (42)

1. Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-31.
2. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) 1 : causes and death rates. Diabetologia 1990; 33: 538-41.
3. Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G. Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabetic Med 1994; 11:636-45.
4. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990; 13: 153-69.
5. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
6. Jarrett RJ, Viberti GC, Argyropoulis A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabetic Med 1984; 1: 17-19.
7. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-41.
8. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W. Morbidity, mortality and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice. Diabetic Med 1992; 9: 646-53.
9. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDA1. Diabetes Care 1993; 16: 996-1003.
10. Damsgaard EM, Froland A, Jorgenson OD, Alogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300.
11. Beatty OL, Ritchie CM, Bell PM, Hadden DR, Kennedy L, Atkinson AB. Microalbuminuria as identified by a spot morning urine specimen in non-insulin-treated diabetes: an eight-year follow-up study. Diabetic Med 1995; 12: 261-6.
12. Kumar S. Microalbuminuria in non-insulin-dependent diabetes mellitus. Diabetic Med 1995; 12: 647-8.
13. Lie RF, Schmilz JM, Pierre KJ, Gochman N. Cholesterol oxidase-based determination by continuous-flow analysis of total and free cholesterol in serum. Clin Chem 1976; 22: 1627-30.
14. Bucolo G. David H. Quantitative determination of serum triglycérides by the use of enzymes. Clin Chem 1973; 19: 476-82.
15. Nicol DJ, Davis RE, Curnow DH. A simplified colorimetric method for the measurement of glycosylated haemoglobin. Pathology 1983; 15: 443-7.
16. Marre M, Claudel J, Ciret P, Luis N, Suarez L, Passa P. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 1987; 33: 209-13.
17. McCann VJ, Knuiman MW, Stanton KG, Winter MG. Mortality and coronary heart disease in diabetes mellitus. Aust J Public Health 1994; 18: 92-5.
18. Cox DR. Regression models and life tables (with discussion). JR Stat Soc 1972; 34: 187-220.
19. Hosmer D\V, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
20. Statistical analysis system. Version 5. 1989 SAS Institute Inc., Cary NC, USA.
21. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arteriosclerosis and Thombosis 1993; 13: 205-10.
22. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 731-5.
23. Melton LJ, Ochi JW, Palumbo PJ, Chu C. Referral bias in diabetes research. Diabetes Care 1984; 7: 12-18.
24. Gall MA, Rossing P, Skott P et al. Prevalence of microand macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 diabetic patients. Diabetologia 1991; 34: 655-61.
25. Klein R, Klein BE, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993; 16: 1325-30.
26. Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991; 8: 706-11.
27. Mogensen CE, Vestbo E, Poussen PL et al. Microalbuminuria and potential confounders. Diabetes Care 1995; 18: 572-81.
28. Abbott MC, Sanders LR, Bakris GL. Microalbuminuria in non-insulin-dependent diabetes mellitus. Arch Intern Med 1994; 154: 146-53.
29. Damsgaard EM, Mogensen CE. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabetic Med 1986; 3: 430-5.
30. Connell SJ, Hollis S, Tiszen KL, McMurray JR, Dornan TL. Gender and the clinical usefulness of the albumin:creatinine ratio. Diabetic Med 1994; 11: 32-6.
31. de Grauw WJ, de Lisdonk EH, van den Hoogen HJ. Screening for microalbuminuria in type 2 diabetic patients: the evaluation of a dipstick test in general practice. Diabetic Med 1995; 12: 657-63.
32. Wilson P\V, Evans JC. Coronary artery disease prediction. Am J Hypertens 1993; 6: 309S-313S.
33. Samler J, Vaccaro O, Neaton JD, \ventworth D. Diabetes, other risk factors, and 12-Yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
34. Jensen T, Feldt-Rasmussen, Bjerre-Knudsen J, Deckert C. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; i: 461-3.
35. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
36. Deckert T, Feldt-Rasmussen B, Borch-Johnson K, Jensen T, Kofoed-Evenoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26.
37. Zimmet P, Cohen M. The diabetes epidemic in Australia: prevalence, patterns and the public health. MedJAust 1995; 163: 116-7.
38. Welborn TA, Glatthaar C, Whittall D, Bennett S. An estimate of diabetes prevalence from a national population sample: a male excess. Med J Aust 1989; 150: 78-81.
39. Glatthaar C, Welborn TA, Stenhouse NS, GarciaWebb P. Diabetes and impaired glucose tolerance. A prevalence estimate based on the Busselton 1981 survey. MedJAust 1985; 143: 436-40.
40. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. Br Med J 1993; 306: 1313-8.
41. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type 2 diabetic patients. Ann Intern Med 1994; 1I8: 577-81.
42. Alzaid AA. Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 1996; 19: 79-89.